Solutions Industry Ltd (PSI) a member of Ambah Group is the
leading sterile injectable manufacturer in Middle East and Africa.
Our manufacturing facilities in Saudi Arabia are GMP certified and equipped with the latest production technologies with over 40 years of proven reliable experience worldwide in contract manufacturing of parenteral solutions in plastic and glass bottles, plastic bags, as well as plastic ampoules.
Recently, Ambah/PSI has developed the first Ibuprofen intravenous (IV) infusion in the world (400mg/100ml). Successfully registered as Ambaprofen and Ambafen (Ibuprofen 400mg/100ml IV Infusion) through the health authorities in Germany, Spain, and Saudi Arabia, its patent has been granted by the European Patent Office (EPO patent no: 2636406) and United States Patent and Trademark Office (uspto Patent No: US 9351926 B2) for its dosage form with the approval of the European Medicines Agency (EMA).
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has approximately 6,500 employees in its operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States. Amneal is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States, with an expanding portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. The Company markets a portfolio of branded pharmaceutical products through its Impax Specialty Pharma division focused principally on central nervous system disorders and parasitic infections. For more information, visit www.amneal.com.
ANFARM SA, a dynamic manufacturer of quality generics since 1967,
promotes its own products worldwide and acts as a third party
manufacturer for multinational companies.
- Lyophilized & Sterile products
- Cephalosporins & Carbapenems
- Non-Sterile Products
AqVida is a German pharmaceutical company, specialized in development and production of oncology generics. A wide range of oncology products (parenteral and solid forms; MAs granted in Europe) are available for immediate MA transfer. AqVida is producing its oncology injectables in its new and innovative robotic manufacturing site in Germany.
A leading pharmaceutical company engaged in R&D, manufacturing and marketing of high quality medicinal products with special focus on CVS/CNS areas. Our manufacturing sites comply with EU/FDA GMP. Ginkgolide injection is a global innovative herbal medicinal product of its kind for treatment of mild-moderate cerebral infarction. Other generic products are Enoxaparin sodium injection, pantoprazole sodium for injection, etc. Over 20 generic drugs are under development. We also provide contract manufacture service of liquid injectables, lyophilized, tablets and capsules and cooperate with firms to introduce high-end pharmaceutical products into Chinese market.Baiyu are open to any business cooperation that can bring benefits to both sides.
Baxter Pharmaceuticals India Private Limited (erstwhile Claris Injectables Private Limited) is the Ahmedabad-based Generic Injectables Arm of Baxter. In Ahmedabad, Baxter Pharmaceuticals India Private Limited (BPIPL) formulates, fills and finishes a broad portfolio of essential generic medicines with complementary strengths in anesthesia and analgesics, critical care and renal medicines and anti-infectives in a variety of presentations including bags, vials and ampoules. Our manufacturing site is home to state-of-the-art manufacturing infrastructure, which follows the most stringent quality controls and is approved by international regulatory authorities. We are a leader in number of manufacturing technologies including Emulsion Remixing, PVC / Non – PVC bags, Glass Vials and Glass Ampoules. We have a 15-year track record of successfully launching new products around the world, with more than 50 products on-market today across the world and a pipeline of more than 100 new products in development.
Bespak is a leading developer and manufacturer of complex medical devices.
Our service offering can be divided into three categories: proprietary devices and technologies, scale up and industrialisation of an already-designed device, and design and commercialisation of a novel device for an existing drug.
As a high-volume manufacturer, we supply respiratory drug delivery devices, valves and actuators, injectable devices and medical check valves into major European and US markets, and our facilities are FDA-inspected and approved.
Major pharmaceutical companies work with us because of the quality of our development services and products, the technical knowledge, skills and experience in our team, our world-class facilities and our desire to build rewarding, long-term relationships based on excellent customer service.
Biem Pharmaceuticals, with headquarters in Ankara - Turkey, founded in 1989, is a privately held pharmaceutical manufacturer and distribution company focused on offering effective treatment options in Oncology, Hematology, Radiology, Ophthalmology and Transplantology fields.
Blau Farmacêutica, is a Brazilian multinational company and a pioneer in the development of recombinant proteins currently producing, bio-pharmaceuticals and Bio-similar selling in Brazil and several countries around the world. The hospital and pharmaceutical Blau line consists on an extensive and varied range of simple and complex products for treatment of several diseases, with 30 years of marketing focused in innovation and technology and with 5 subsidiaries at Latin America: Uruguay, Argentina, Colombia, Chile and Peru and soon will open one more subsidiary in Latin America.
BMI Korea, regardless of a short history from 2005 in Korean Pharmaceutical industry, has been rapidly growing & connecting into local, worldwide societies for “healthy life of human-being” with the industry's outstanding spotlight & concentration, which is derived from each BMI member's voluntary & creative R&D approach, non-stop challenge & passion, and young but most dynamical corporate's working environment for the future corporate's core value, to jump toward a global player. With a horizontal intergration of BMI's professional experiences, know-hows & novel technologies, BMI- Korea has been always putting all of effort, energy for development of differentiated & novel biopharmaceuticals & medical devices and beyond this, we - on behalf of all BMI members, promise to challenge our goal & dream to care for the best health of every human-being and to become a global leader in 21th century's healthcare industry.
Boryung Pharmaceutical Company, aiming to be the best not the biggest, started since 1957 and has put a strong presence in Korean market as one of TOP leading pharmaceutical companies.
Boryung has invested continually on research and development and made
continuous efforts to produce high-quality products. Lately by
new drug, Fimasartan (8th
Angiotensin Receptor Blocker over the world) with its own R&D,Boryung
is accelerating its R&D activity to become the global health care company.
Boryung has continued to expand the global network and now, it's partners and markets cover Japan, China, ASEAN, Europe, Latin America, Middle East, and Africa.
Founded in 2001, Caregen is a global leader of research and marketing of Biomimetic Peptides and Growth Factors. Caregen is not only the company to register Growth Factors in PCPC (Personal Care Products Council, formerly CTFA) but also possesses various Biomimetic Peptide patents all around the world. At Caregen, we value innovations and ideas. With highly skilled in-house scientists and marketing specialists with years of experience in developing and manufacturing of innovative active ingredients, we offer a sophisticated line of purified Biomimetic Peptides and Growth Factors at affordable prices, which is made possible from our mass production technology, enabling our current and prospective customers to have the advantages that they always needed. Additionally, we offer customized Biomimetic Peptides and toll manufacturing services that will provide our customers the solution to their research and manufacturing challenges.
Centurion Pharma is a Turkish Company located in Istanbul and began its journey in 1949. The core business is importing, developing and manufacturing products directed towards use in treatment of chronical and rarely encountered diseases. The product portfolio range consists of:- Biological plasma products -Biosimilar products -Hospital products -Vaccines. Centurion Pharma, which believes that every patient deserves modern treatment alternatives and high quality of life, invested in special R&D projects in the last 5 years, and it has taken a giant step for specific and special products to be manufactured in Turkey. Centurion Pharma embraces respect for both Humans and Nature.
Chemi SPA has
relevant expertise in the area of Low Molecular Weight Heparins,
Polysaccharide Derivatives, Peptides and Oncology Products.
Pipeline of several technology-innovative products and generic Finished Dosage Forms with granted Marketing Authorizations and dossiers available for licensing
We, Ciron Group of Companies, are WHO-GMP approved manufacturers and exporters of generic pharmaceuticals. Exporting to Africa, Latin America and Southeast Asian markets. We manufacture a wide range of dosage forms including small volume liquid injections, lyophilized products, ophthalmic drops, powder injection, liquid oral, ointment, cream, gels, tablets, capsules, dry syrups. We currently have two manufacturing site and we are coming up with a third site targeted towards regulated markets. Our regulated market site is targeted toward EU MHRA and USFDA guidelines, and we are looking for partners for this project.
Divasa-Farmavic,S.A. is one of the few EU veterinary manufacturers with fully GMP approved facilities to manufacture: >Beta-lactam and non-beta-lactam totally separate production lines for injections/solids: Sterile Solutions, aseptic and terminal sterilization. Sterile Suspensions. Extemporaneous powder for injections. Oral Soluble Powders. Medicated Premixes. >Aerosols >Pets collars >Oral and topic solutions
Dongkook Pharmaceutical was founded in 1968 and since its foundation, Dongkook has concentrated on R&D and technology innovation. Dongkook is well known for OTC products of high brand values in Korea. Additionally, Dongkook has developed and produced outstanding therapeutic products including anesthetics, contrast media and anti-cancer agents. Dongkook has been recognized by domestic and foreign authorities for its quality of finished products, medical devices and APIs. Currently, Dongkook exports the finished products, medical devices and APIs to over 50 countries around the world, and seeks to grow into a global leading pharmaceutical company.
Dorizoe Lifesciences Ltd is a purely Contract Research & Finished Product Development Organization based in India, working for Pharmaceutical Companies operating in Regulated Markets. We have strong capability in Finished Product Development of Parentral, Injectable (Lyophilized to Aqueous in Cytotoxic and Non Cytotoxic space) & Semi-Solids Like Creams, ointments & Gel in different delivery systems including Ampoules, Vials, PFS, PVC and Non - PVC bags and so on. At Dorizoe, we have very strong capability of developing injectables in cytotoxic to non cytotoxic space in lyophilized to aqueous form. After developing the product, we can also assist you for contract manufacturing by transferring the technology to your preferred CMO or at our recommended / preferred CMO partners. Apart from contract development, we also provide the Customized Services of Formulation and Development, Analytical Service, Quality Assurance, Regulatory Services and other Pharmaceutical Support Services. Currently we are working with the top pharmaceutical company of the world and providing services for parenteral development as well as technology transfer for their injectable products.
Apart from contract product development, we are also working on in our in house development projects whereby we will be developing the product till TTDs(Technology Transfer Dossiers) and out licensing readily available TTDs to our prospective clients in global market place. For these TTDs, we will also assist our client for tech transfer to their preferred CMO.
Emergent BioSolutions (acquirer of Cangene bioPharma) provides contract manufacturing services for both bulk drug substances and finished drug products. Emergent's state-of-the-art single-use BDS facility enables turnkey upstream and downstream support for microbial, mammalian and viral cell lines. Emergent's Fill/Finish service offering includes vials and syringes, for both liquid and lyophilized products (including lyo cycle development). Emergent's manufacturing facilities (located in Baltimore, MD) currently produce 20 commercial products and supported over 200 clinical drug products. For more information, visit www.emergentcontractmanufacturing.com
ESSETI FARMACEUTICI is an Italian pharmaceutical company that from its beginning in 1956 has invested in the internationalization process anticipating times on competition, tracing new paths in the export of Italian production, a best banner in the world capable of transmitting and ensuring high quality standards and competitive prices in many markets. The products of our therapeutic areas combine top quality active ingredients made in Europe with innovative and excellence of the manufacturing process. The concept that characterizes the philosophy of our company is orientation to results, dynamism, innovation and attention to the international market.
EVER Pharma is an Austrian based fully integrated specialty
pharmaceutical company focused on research, development, production and
commercialization of innovative therapies and value-added formulations. Our
product portfolio and pipeline currently covers the therapeutic areas of
neurology, critical care, anesthesia and oncology. Our finished dosage form
products are developed and manufactured at our EU GMP certified facilities in
Austria and Germany and marketed in more than 70 countries around the world
through affiliated companies and strategic partners.
In addition to our own product portfolio, we offer years of experience and ‘know-how' in providing full service manufacturing for global partners. Covering fill & finish, QC, stability testing and warehousing we provide high quality sterile production of ampoules, vials, syringes and implants. Our extensive specialized service capabilities includes the production of highly complex injectables such as high potency substances, crystal suspensions and oil based formulations.
Fabtech is a global Engineering and Fabrication company
specializing in innovative turnkey solutions for Healthcare, Pharmaceutical
& Biotech Industry, with In-house design, engineering,
construction and manufacturing of critical and vital elements. We have in-house
Installation team to execute and commissioning. With over 20 years of
experience, and more than 700 installations in over 42+ countries, we have
grown into one of the leading engineering and construction partners for
pharmaceutical and allied industries.
Turnkey Solutions we provide are:
Consultancy and Technology Transfer.
Cleanroom Modular Partitions (Design & Manufacturing, Installation & Commissioning)
Cleanroom Equipment (Design & Manufacturing, Installation & Commissioning)
HVAC System (Design, Supply, Installation & Commissioning)
Process Equipment – GRANULATION EQUIPMENT, CAPSULE FILLING MACHINE , STERILE LINE - VIAL , AMPOULE & PFS (Design & Manufacturing, Installation & Commissioning)
Containment Solutions – Isolators (Design & Manufacturing, Installation & Commissioning)
Water treatment System - (Design & Manufacturing, Installation & Commissioning)
We are growing at CAGR of 32%, with 72% repeat clients in India and Internationally. We have carried out operations in more than 42+ countries worldwide.
It is noteworthy to state that Fabtech is currently one of the MOST preferred company for executing Pharma projects, recently having bagged a Turnkey Pharma Projects for complete internal infrastructure.
We are one of the companies internationally to have own manufacturing of pre-fabricated panels, Cleanroom Equipment , Granulation Equipment , Capsule Filling Machine, Liquid Line (Vial , Ampoules and PFS) , Water Sytems & Containment solutions. We currently enjoy a strong presence in Asia, Middle East, Europe , Africa and US are constantly aspiring to increase our global footprints.
Frontier Biotechnologies Inc. is a research-based pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing significant unmet medical needs. - Its lead product candidate ALBUVIRTIDE, a novel long-acting anti-HIV agent. - The second lead drug candidate AB001 is a third generation topical patch for the management of pain and inflammation, and a phase 2 clinical trial of AB001 for the treatment of chronic low back pain was successfully completed in the US. - Frontier Biotechnologies, Inc., announced it has signed an agreement with The Rockefeller University of the US for the worldwide license for combining 3BNC117, a novel broad-spectrum HIV neutralizing antibody, with ALBUVIRTIDE for the treatment and prophylaxis of HIV infection and AIDS.
Grifols Partnership is a business to business contract development and manufacturing platform (CDMO) specialized in small molecule intravenous solutions for the pharmaceutical industry. Grifols Partnership undertakes all commitments with great enthusiasm; our objective is that your product reaches the market on time, and in optimum conditions. Technological capabilities:- Aqueus LVP and SVP- Emulsion technology- Form Fill Seal (FFS) technology for PP bags- Manufacture and filling of oxygen and light sensitive products- Terminal sterilization
Harbin Medisan Pharmaceutical Co., Ltd (abbreviated as Harbin Medisan) is a national high-and-new-tech enterprise that engages in R&D, manufacturing and sales of chemical pharmaceutical finished dosage forms and APIs. It has four wholly owned subsidiaries and one joint stock company, with the registered capital of 211 million Chinese Yuan. Harbin Medisan owns 13 production lines, with the production capacity of 30 million vials of small volume injection, 150 million vials of lyophilized powder for injection, 150 million tablets (capsules) of solid dosage form, 300 million bottles (bags) of infusion solution, and 4 metric tons of API. The main products include: Oxiracetam injection, Alanyl glutamine injection, Cerebroprotein hydrolysate for injection, Ligustrazine hydrochloride for injection, Ossotide for injection, Mirtazapine tablet, Glucose injection, Sodium chloride injection. The dosage forms include small volume Injection, lyophilized powder for injection, solid dosage form, non-PVC soft bag infusion, plastic bottle infusion, glass bottle infusion and API etc. The sales network covers all over China.
Hikma puts better health within reach, every day. We create high quality medicines and make them accessible and affordable to people who need them. Global experts with a local presence, we think creatively and act practically, transforming cutting-edge science into innovative solutions that transform people's lives, for a healthier world wherever we are.
WE are a WHO: GMP Certified company from India manufacturing & marketing more than 300 different types of formulations - Tablets, Capsules, Liquid Injections and Oral Dry Powders lines. These products are manufactured for the human, as well as veterinary, markets. We can provide COPPs and dossiers. Associate company RAALI HEALTH is in Canada.
IRA Istituto Ricerche Applicate is specialized in the production of class I, IIA, IIB and III CE-marked Medical Devices for contract manufacturing, providing cutting-edge and innovative technology in the research & development and productive processes. IRA's strength lies in the production of injectable class III CE0373 marked Medical Devices made of Linear & Crosslinked Hyaluronic Acid, for aesthetic & intra-articular use, which have high levels of purity, low concentration of nucleic and proteins and endotoxin levels 0.5 EU/mL, which is significantly lower than European Pharmacopoeia limits for injectable products. Thus, our Company has specialized in the development of products which comply to the rigorous standards for stability, purity and technique. IRA is also a reknown manufacturer of raw materials for cosmetic use as delivery systems of active ingredients. Certifications: UNI EN ISO 9001:2008, UNI EN ISO 13485:2012, UNI EN ISO 22716:2008, EFfCI GMP Guide for cosmetic ingredients.
IBI Istituto Biochimico Italiano G. Lorenzini S.p.A. is an independent Italian research-based pharmaceutical company pioneer since 1918 in the development, production and marketing of medicines worldwide. Following our mission of “creating to contribute”, we have used innovative technology to develop a portfolio of products to improve the health of patients. IBI is present has an established leadership in penicillin market and capability of aseptic filling for injectable drug products aimed for different therapeutic areas. IBI's high quality standards is internationally recognized by the most demanding health authorities : AIFA, US FDA, EDQM, TGA and PMDA. R&D is one of the strengths of the Istituto Biochimico Italiano. Thanks to the fact that many manufacturing processes have been developed entirely in house; from the semi synthesis of active substances (ß-lactam) to the development of the formulations, the company has obtained numerous patents. Investment in resources and in innovative equipment enables us to continuously improve production and analytical processes.
- Unit-I (G-Block): Incorporated in 2006
- Unit-II (C-Block): Incorporated in 2010
- Unit –III (G-Block): Incorporated in 2017
As Istem Medikal employees, together with our business partners, we serve our customers by manufacturing and supplying innovative, reliable and environment friendly medical devices. We diligently value our brand and its benefit to society. Istem Medikal is an establishment that takes place in sales and marketing area of medical sector since 1995. In order to utilize its experience and accumulation which was gained by years , Istem Medikal founded its own manufacturing facility in 2007 and since that time it becomes to produce the marketing goods itself. Although it is a new company in manufacturing, it does not take so much time to begin the production of hydrophilic catheter in the world standard due to its wide knowledge of industry and also experienced team. Because of the consciousness how important is the quality and scientific support in production, it has achieved to take R&D support of the scientific organizations such as TUBITAK Turkish Scientific and Technical Research Institution and SAN-TEZ by Turkish Ministry of Industry & Trade. Moreover, the leading support of technology partners in principal universities made serious contribution to our strength. Today Istem Medikal has become the leader of the sector which has also started to export aiming to get the first place in the international arena . Therefore our initial goal is to study more and more for human health protection for both Turkey and worldwide. With this respect ,it becomes our principle to improve the quality of our products and to maintain self-development with increasing product variety groups every year. Our vision is to accelerate the development of health sector doing the best that we can . We realize it without sacrificing our quality. Furthermore, we encourage our production department with training programmes. We also follow the development in automation technology step by step and apply it to our production systems. We have performed a first in the production of hydrophilic catheter. We generate our own resources and use them in all phases of production thus we created a production department. ISTEM MEDICAL that has EN ISO 9001:2015 and EN ISO: 13485:2016 quality certificates aims to be the pioneer in the sector. ?stem Medikal has been granted following quality certificates; ISO 9001 : 2015 ISO 13485 : 2016 CE QUALITY MANAGEMENT SYSTEM CERTIFICATES Class I SterIle Class IIa Class IIb CE DESIGN EXAMINATION CERTIFICATES Class III Istem Medikal has registered trademarks and has some international patents rights of the technologies that she developed.
Jiangsu Hengrui Medicine Co., Ltd., established in 1970, having over 13,000 employees globally, is the largest manufacturer of antineoplastics in China. Its operating income was over USD 1.7 billion in 2016. The company stock was officially listed on the Shanghai Stock Exchange in 2000. All APIs and finish dosage forms have passed national GMP authentication. For APIs, we got approvals from US-FDA, EDQM, PMDA and TGA. For FDFs, we got approvals from US-FDA, EU and PMDA.
We, Jodas are a Hyderabad (India) based pharmaceutical company with world class product development and manufacturing capabilities at it's core of operations. All our efforts are towards increasing affordability and accessibility to much needed high cost finished pharmaceutical products. We mainly cover three therapy areas: Oncology Contrast Media Critical Care products, including most of the anti-infectives Cephalosporins
Kopran Ltd is international pharmaceutical marketing and manufacturing company. We have two WHO GMP approved factories. Our facility at Khopoli for FDF's is approved by TGA, MHRA and MCC and our API facility at Mahad is WHO GMP accredited. We export to major markets in Europe, SE Asia and Latin America.
We, Korea United Pharm. Inc., specialized in the human healthcare field, have been manufacturing, marketing, and selling pharmaceutical products since 1987. We have a broad range of products from OTC and ETC including about 30 kinds of anti-cancer products. These products are being exported to over 42 countries around the world. we are investing over 10% of annual turnover in R&D and seeking to expand our product portfolio, focusing on development of IMC(Incrementally Modified Drugs) products with less side effects & improved drug compliance.
We have brance offices in the Philippines, Myanmar, Vietnam and Indonesia. These worldwide organizations will help to provide high-quality healthcare products and good services promptly to customers.
For further information, please visit our website(www.kup.co.kr) and contact us without hesitation.
Lesvi, part of Neuraxpharm, is strategically focused on the development, manufacture and marketing of drugs indicated for the treatment of the Central Nervous System (CNS) among others. Lesvi has broad experience in the development and manufacturing of finished dosage forms allowing us to become the reliable partners for both large national and international third-party laboratories. More information is available at www.neuraxpharm.com
Lodaat Pharma is a USA science based firm which provides Innovation to Generic Pharmaceuticals, Nutraceuticals, and Botanical Ingredients. We produce finished formulations, Dossiers and Tech-Transfers. (http://www.lodaatpharma.com)
We manufacture innovative Super-Generics in all major therapeutic categories including; Oncology, Antibiotics, Cardio and a broad range of USFDA nutraceuticals. We specialize in botanical molecule-extracts. Our USA Science team has recieved Awards for Tech-Transfers to Emerging Markets.
We are looking for Long-Term Partners:
- 1) Licensing of our USFDA, UKMHRA Generic Pharmaceuticals to Emerging Markets
- 2) Distribution Partners for our USA made Nutraceuticals (Vitamins, Herbal medicine, Supplements)
- 3) Supplying our Award winning Botanical Extracts, molecules to manufacturers
- 4) Tech-Transfer of our CTD-Dossier Generics to CMOs
BEST EXPORTER AWARD- USA State of Illinois, 2014 and 2016
OFFICIAL KNOWLEDGE PARTNER CPHI Worldwide
CHAIR OF BONE-JOINT HEALTH- Geneva, Switzerland
Medichem is a vertically integrated pharmaceutical company that is specialized in the development and manufacture of API and FDF for the global generics industry. It offers a vibrant portfolio of about 60 APIs and 30 FDFs, including highly potent products, as well as a wide range of services, ranging from R&D development to contract manufacturing and licensing. It is also a world-leader in Chlorhexidine products. The group boasts of over 45 years of experience in the sector, and guarantees the highest standards of quality, operational excellence and respect for the environment. It is made up of a workforce of over 460 talented individuals located in various countries including Spain (HQ), the USA, Malta and China.
Your North American Specialty Pharmaceutical Partner
Methapharm is a privately held specialty pharmaceutical company with a focus on the acquisition, licensing, and promotion of healthcare products in North America. We market our own proprietary products as well as partner with global companies to deliver a comprehensive line of specialty products in the USA and Canada.
As an integrated specialty products company, we offer our partners sales and marketing, distribution, market access, regulatory, quality, medical, and pharmacovigilance capabilities in North America. We are part of the ACIC group of companies which operate in the fields of API and finished product development, manufacturing, and supply. Come visit us at CPhI - or contact us to make an appointment.
Natco Pharma Limited based in Hyderabad, India, is a leading manufacturer and exporter of API's and Finished Dosage Forms. Natco has proven technical and operational expertise of over three decades in developing and commercialising APIs and FDFs. Our unwavering commitment to quality; cGMP compliance to deliver affordable drugs with novelty, and improving market access for patients across the world is at the core of everything we do.
A private specialist biotech company. We have expertise in the Commercial development from concept to product launch, of systems including: Transdermal Patches, Complex Injectables, Re-formulating Biologics, and Dermal and Topical drug Delivery.We have several Proprietary Platform technologies including micro-solid dose injector, micro needle injectors, and Intramuscular Injector devices, available for use with new and old drug molecules with a wide range of physicochemical properties as well as dosage requirements. We provide cost-effective tangible differentiation of existing drugs, and unique systems for delivering new drugs. Our facilities in the UK include Pharmaceutical development Laboratories, GMP IMP suite for aseptic and non-aseptic drug product manufacture, and A Schedule II controlled drugs license.
Established in 1982, Neon has earned reputation as one of the leading pharmaceutical companies in India. Over the last three decades, Neon has successfully explored new horizons in the industry with core initiatives to lead the company through innovation and research. Furthermore, Neon has established their global presence by supplying high quality branded generic formulations. We are leaders in Anesthesia segment with the product basket of 40 plus molecules. We specialized in various Lidocaine & Bupivacaine dosage forms. Our key areas of business are Formulation, API and Medical Devices. After attaining leadership position in Domestic Market, Neon now aims at achieving substantial position in International markets. Joint venture and tech transfer has given a great boost to the growth of the company.
Aspiring to continuously add value in healthcare industry, we endeavor to lead the company with total integrity and highest ethical standards, by predominantly emphasizing on the wellbeing of our teammates (Stakeholders) and the communities we serve.
Our Mission is to become a global leader in the Healthcare industry by offering the world class quality products and consistent services. We constantly strive to expand our manufacturing facility by adopting the latest technology and investing in R&D, to assure quality products at affordable prices to our customers and business partners.
We have four manufacturing plants at different locations with fully equipped state-of-the-art technology and modern infrastructure. We always maintain current GMP standard prescribed by W.H.O. We have a team of highly educated and expert professionals with long-term experience in the pharmaceutical industry. We are capable of supporting small as well as big volume batch sizes. For Lyophilized products, we have an ice condensing capacity of 10kgs, 100kgs & 300kgs. Our team of veteran professionals works with complete dedication and enthusiasm in order to deliver our customers best products and services across the globe.
We have a field force of over 1000 medical representatives all over India that strengthen our marketing activities and cover each and every hospital in India. We take lot of efforts in training and developing our Marketing team so as it becomes integral part of the company.
We have following divisions dedicated to specific therapies ANAESTHETIA DIVISION, CRITICARE DIVISION,MAXNEON DIVISION , OMACRAE DIVISION , MAXICARE DIVISION. Six of our brands are leading brands as per ORG-MARG. We have over 28 distributors and we have more than 500 products being regularly sold in India.
With an aim to grow in the international market, we have spread our business in several countries of ASIA, Africa, Latin America and CIS, with further expansion plans in regulated market. Our regulatory department is efficient & has registered more than 300 products in 60 different countries. We also strive to make tie-up with international companies in order to build a global network through our proficiency, long-term experience, implementing new technology as well as the hard work of research team and business associates.
Our core business is development and production of Parenteral Formulations i.e. Dry powders, Liquid Injections, Pre-Filled Syringes and Lyophilized injections. We have persistently expanded our spectrum of business by developing, licensing, manufacturing and marketing many key products. We also specialize in developing formulations and APIs (Active Pharma Ingredients) on contract basis for our reliable partners with complete confidentiality and exclusive agreements.
We cater to following therapeutic segment
• Critical care
• Medical Device
• Other Healthcare products
Our R&D facility
We have fully equipped R&D facility which becomes the heart of our company. For more than three decades, with the help of our R&D experts, we have achieved many milestones and successfully launched 7 brands/molecules 1st time in India like
Myo-Pyrolate (Neostigmin+Glycopyrrolate) Cloneon (Clonidine) Potphos (Potasium Phosphate) Nelcium ( Calcium Chloride) Sodac 8.4% (Sodium Bicarbonate) R&D has helped us to earn a reputation in the market as a most trusted name for supplying the best quality healthcare products.
OPKO Health Spain is part of OPKO Health Inc, a multinational company based in Miami. At OPKO Health Spain we are committed to continuous innovation through the development of products and new technologies that contribute to improve the health of people and pets. Our products are aimed at correcting degenerative processes, through specific ingredients that act as precursors to essential structures. We offer a diverse portfolio of food supplements and medical devices for several therapeutic areas, including osteoarticular, opththalmic and others. Through our network of partners we are currently distributing our products in more than 30 countries worldwide.
Pharma Bavaria International (Germany), markets highest-German/EU-quality pharmaceutical brands with well-researched ingredients in > 40 countries. In line with our vision: Access to Quality Healthcare we offer our products in emerging economies in MENA, Asia, CIS and LATAM. Our Rx portfolio is being constantly expanded by OTC products and medical devices.
Pharmaniaga Berhad is a member of Boustead Group of Companies which is of a Government Linked Company status listed in the Main Board of Bursa Malaysia. The Pharmaniaga Group's core businesses are generic pharmaceuticals manufacturing, research and development, marketing and sales, warehousing and distribution of pharmaceutical and medical products as well as supply, trading and installation of medical and hospital equipment.
The capabilities of its two manufacturing plants allow the Pharmaniaga Group to deliver on its commitment to bring quality, affordable medicines to the community. One plant is equipped with production facilities for solids, liquids, "cephalosporin dry powder" injectables and "beta-lectam" antibiotics, together with state-of-the-art quality control and assurance laboratories, and modern research and development facilities; while the other plant is poised to be the low cost supplier of Small Volume Injectables (SVI) products in vials and ampoules to the regulated markets of Europe and the US.
The Group's manufacturing arm offers high quality and cost competitive contract manufacturing services, supported by its regulatory services, sales & marketing capabilities and distribution network.
Pharmaniaga holds 10-year concession to supply and distribute pharmaceutical and medical products to hospitals and medical institutions under the Ministry of Health. Strong regional presence in Vietnam, Indonesia, Brunei, Singapore, Papua New Guinea, Fiji, Myanmar, Cambodia, Hong Kong, the Phillipines, Zimbabwe, Sudan, Sri Lanka, Kenya, Iraq and Macau.
With a vision to be the premier Malaysian pharmaceuticals company, Pharmaniaga is guided by its philosophy of "doing business with a conscience" and empowered by its mission of Passion for Patients to , making it your ideal sourcing partner in this region.
Link for Contract Manufacturing Services :https://drive.google.com/file/d/0B9PLXWJN3HPhdU5uTXVYTjE5Mmc/view?usp=sharing
Link for Product List : https://drive.google.com/file/d/0B9PLXWJN3HPhNHZSajN2V2ZZdDg/view?usp=sharing
SamChunDang (SCD) Pharm. Co., Ltd. is the leading pharmaceutical company specialized in ophthalmic products in Korea. We have acquired EU GMP certification and have been under preparation for CGMP approval for both manufacturing sites of multi-dose and single-dose products. Since establishment in 1943, we have been providing a high quality pharmaceutical product for the purpose of providing healthier and happier lives for everyone. We provide safety and convenience and also offer a wide range of choices with multi-dose, and preservative-free single-dose eye drops. We have been exporting pharmaceutical products to more than 25 overseas countries for more than 20 years and have been seeking to expand into the global market with EU GMP certified technology.
Sandoz GmbH develops and manufactures healthcare products. Its product line includes bio-similars, inhalers, patches, injectables, and oral solids. The company was formerly known as Biochemie GmbH. The company was founded in 1946 and is based in Kundl, Austria. Sandoz GmbH operates as a subsidiary of Sandoz International GmbH.
Savior Lifetec Corporation (SLC) is a specialty pharmaceutical company based in Chunan, Taiwan; our facilities are vertically integrated, capable of producing sterile API and finished dosage formulations. Our facilities have passed GMP inspections by authorities from the US, EU, and Japan. SLC also has GLP compliant R&D centers for API research and pharmaceutical research. SLC's expertise in sterile crystallization and the aseptic processing of sterile powder serves as the foundation for product innovation.
Shandong Kexing Bioproducts integrates R&D, manufacture, and sales of biopharmaceuticals. Genzon Group and Shenzhen Kexing Biotech Co Ltd are its major stock holders.
Its production site offers Recombinant Human Erythropoietin Injection(EPO), Recombinant Human Granulocyte Colony-stimulating Factor Injection(rh-G-CSF)Filgrastim, and Combined Clostridium Butyricum and Bifidobacterium Powders, Live for clinical and commercial use. I
The company develops recombinant genetic biological drugs and micro-ecological preparation, to serve the clinical treatment needs of kidney diseases, tumor, and gastrointestinal diseases. It has become a leading player in China's biopharmaceutical industry after more than 10 years of development.
- No.1 Chinese producer of Recombinant Human Erythropoietin Injection(CHO Cell)
- One of leading bio-pharmaceutical suppliers in China
- EPSINO is the first EPO Product put in Chinese market
- The only EPO product free of human albumin in China
- First-class G-CSF
- Non-toxic certain bacteria combination
- Diversity of target markets for treatment of renal disease, tumors, gastrointestinal tract disease
- Advanced market- oriented R&D capabilities
- Mature domestic marketing network
- High-efficient international sales team
- Improved market-oriented management team
- Strict quality management system to ensure safety,effectiveness and stability
Established 1921 in Switzerland, Sintetica is a pharmaceutical company delivering injectable anaesthetics, analgesics and neuromodulation drugs to patients worldwide, through innovative science and excellence in development, production and marketing. Our sites are located in Switzerland, Germany, Austria, Italy and United Kingdom. The headquarters is in Mendrisio, Switzerland. The Swiss manufacturing sites of Mendrisio and Couvet have a production capability: 60 million glass ampoules 10 million plastic ampoules 5.5 infusion bags 5 million vials. To manage the challenges, we are facing as an industry and to leverage the opportunities of the growth we have adopted two different business models. In Switzerland, Germany, Austria, UK and Ireland our national well experienced and professional teams directly promote and market our products. The international expansion is driven by a fast track partner selection and affiliation process in each and every target country of the world. A dynamic portfolio of selected branded medicines, developed to answer unmet clinical needs, is what the Global Division offers to our strategic international partners to build a sustainable and long lasting successful alliance. We are a multicultural company, our employees come from 28 different countries all over the world and they represent the biggest asset for us. That's why we believe in the great place to work culture that promotes creativity, informed risk-taking, an exciting environment and a good feeling in every day work.
SUANFARMA Group was born in Spain in 1993 and is specialized in the development, production and marketing of raw materials and finished dosage forms for the pharmaceutical, biotechnological, veterinary, nutritional and cosmetic sectors. International expansion began immediately following the creation of SUANFARMA, so that by 1994 the first commercial office abroad was opened in China. Subsequently, other international subsidiaries were established in different countries. Currently, Suanfarma´s international activities extend to more than 60 countries on all 5 continents. Through a powerful worldwide network we can provide high quality solutions for each individual client's needs.
Terumo Pharmaceutical Solutions
We develop alliances with pharmaceutical companies on a global scale, using Terumo technology to develop, manufacture and supply carefully crafted solutions to their injectable drug delivery challenges.
We pride ourselves on offering a full portfolio of products and services for the pharmaceutical industry, backed by unrivalled scientific expertise and know-how. By anticipating new trends and maintaining a constant dialogue, we provide a first class customer experience.
TIL HEALTHCARE is a vibrant Pharmaceutical manufacturing and marketing company having strong presence in international market. TIL Healthcare specializes in Manufacturing, Marketing, and Exporting a wide range of proprietary and generic branded formulation. Our core strength lies in our footprint across 54 countries and our prime focus is on building Brands of Pharmaceutical products in International Market. Our manufacturing and supply capabilities include all of the following dosage forms: a) DC granules (Directly Composed Granules or Premix Granules). b) Effervescent Tablets c) Oral Disintegrating / Dissolving Strips d) Tablets & Capsules e) Liquid & Syrups f) Injectables g) Sachets CATEGORY:A. Finished Formulation: a. Amino Acids & Multivitamins b. Antibiotics c. Nutraceuticals d. Probiotics B. Contract Manufacturing C. DC Granules
TRB Chemedica is a medium-sized Swiss pharmaceutical company, with a focus on research, development and marketing of innovative niche products in specific therapeutic areas, including rheumatology, ophthalmology and neurology. We market a range of ethical pharmaceuticals and medical devices, most of which are patented, in more than 60 countries worldwide.
In 2000 Tüm Ekip Pharmaceuticals is established by an Equip (team) of experts on their fields under the management of Mr. Hamza O?uz who has 57 years of experience in Wholesale and Pharma Industry. As a young company, we had a secure, healthy and successful growth in a short time. Currently we have over 90 product licenses including all the pharmaceutical presentations, and over 15 new products in the registration pipeline, Being Turkey's only Local and National Specialized Injectable pharmaceutical producer; we are among leader pharmaceutical companies. We have a large expertise on development and production of all injectable forms including powder, liquid, lyophilized powder, SVP, LVP, PVC & Non-Pvc Bag. We are also unique on the production capabilities as we have 3 completely separated/dedicated sterile production area: Sterile Injectable Cephalosporin, Sterile Injectable Carbapenem, Sterile injectable Penicillin. Additionally, with our sterile liquid ampoule, sterile liquid vial, sterile liquid bag, and sterile lyophilized injectable powder production facility, we are the only Specialized Hospital Pharmaceuticals producer who has the capacity and capability to produce 7 different Sterile forms in Turkey and even among EU countries,
Established in Ankara in 2000, VEM is one of the foremost Turkish pharmaceutical manufacturer that offers variety of pharmaceutical finished products in various forms(vial, ampoule, lyophilization, bottle, tube, tablet, capsule, BFS nebule, auto-injector) for different treatment areas such as intensive care, general anesthesia, local anesthesia, cardiovascular and andrologia.
VEM manufacturing site is located in Cerkezkoy/Turkey within total of 21,000 m2 field which has a 20,000 m2 modern indoor area with ongoing expansions and diversifications.
Production site uses state of the art technology and latest developments in pharmaceutical manufacturing and designed in accordance with cGMP.